MedPath

Comparison of Verofilcon A Daily Disposable Lenses to Somofilcon A Daily Disposable Lenses

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: somofilcon A
Device: verofilcon A
Registration Number
NCT04305912
Lead Sponsor
Coopervision, Inc.
Brief Summary

The objective of the study is to evaluate and compare the performance of verofilcon A to somofilcon A when worn on a daily disposable modality over a period of approximately one week each.

Detailed Description

The study is a prospective, double masked (investigator and participant), bilateral, randomized,one week cross-over dispensing study, which evaluates somofilcon A (test lens) and verofilcon A (control lens).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
51
Inclusion Criteria

A person is eligible for inclusion in the study if he/she:

  1. Is at least 17 years of age and has full legal capacity to volunteer;
  2. Has read and signed an information consent letter;
  3. Is willing and able to follow instructions and maintain the appointment schedule;
  4. Habitually wears soft contact lenses in daily wear, for minimum of 6-months;
  5. Is correctable to a visual acuity of 20/40 or better (in each eye) with the study lenses;
  6. Has an astigmatism of ≤ 1.00 D in subjective refraction;
  7. Can be fit with study contact lenses with a power between -2.00 and -5.00 DS;
  8. Demonstrates an acceptable fit with the study lenses;
  9. Habitually wears single vision soft contact lenses for at least 8 hours per day, 5 days a week, and is willing to wear contact lenses for at least 12 hours a day in the study.
Exclusion Criteria

A person may be excluded from the study if he/she:

  1. Is participating in any concurrent clinical or research study;
  2. Has any known active* ocular disease and/or infection;
  3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
  5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study;
  6. Is pregnant, lactating or planning a pregnancy at the time of enrolment because the associated hormonal changes cause changes in the tear layer which impact contact lens comfort. Verbal confirmation at the screening visit is sufficient;
  7. Is aphakic;
  8. Has undergone refractive error surgery;
  9. Is an employee of the Centre for Ocular Research & Education;
  10. Has participated in the BOXER (i.e. EX-MKTG-107, phases 1 or 2) or MIKI (EX-MKTG-114) Study;
  11. Has participated in any clinical trials within a week prior to the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
somofilcon Asomofilcon ASubjects will be randomized to wear somofilcon A daily disposable lenses for one week and then switch to verofilcon A daily disposable lenses for one week.
verofilcon Averofilcon ASubjects will be randomized to wear verofilcon A daily disposable lenses for one week and then switch to somofilcon A daily disposable lenses for one week.
Primary Outcome Measures
NameTimeMethod
Subjective Ratings for Lens Handling for Lens Insertion1 week

Subjective ratings for Lens handling for lens insertion (0 - 10 integer scale), (0- very difficult, 10- very easy).

Subjective Ratings for Lens Handling for Lens Removal1 week

Subjective ratings for Lens handling for lens removal (0 - 10 integer scale), (0-very difficult, 10- very easy).

Secondary Outcome Measures
NameTimeMethod
Lens Fit - Lens Push-up Tightness1-week

The lens push-up tightness was graded using a 0 - 100 scale (5% steps) where 0% = falls from cornea without lid support, 50% = optimum and 100% = no movement

Lens Fit - Centration1-week

Lens Fit Centration was measured on a scale of 0-3 (0-optimal, 1-slight decentration, 2-moderate decentration but not encroaching limbus, 3- excessive \& occasionally encroaching limbus)

Lens Fit - Post-blink Movement1-week

Post-blink lens movement was measured using an eyepiece reticule while viewing the contact lens in vivo at 8x magnification in primary gaze, in 0.1mm steps

Trial Locations

Locations (1)

University of Waterloo

🇨🇦

Waterloo, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath